ion channel mAbs (Eloxx Pharmaceuticals)

N/A

Report date: 2025/03/20 15:53:48

Base Information

Drug Nameion channel mAbs (Eloxx Pharmaceuticals)

Drug Alias Nameion channel mAbs (Sevion)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionSodium channel protein type X alpha subunit modulatorsVoltage-gated potassium channel subunit Kv1.3 modulatorsSodium channel protein type IX alpha subunit modulators

TargetsVoltage-gated potassium channel subunit Kv1.3Sodium channel protein type X alpha subunitSodium channel protein type IX alpha subunit

Therapy Area/IndicationsPainAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEloxx Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesEloxx Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsPainAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A